Athelas Stock

Athelas - rapid diagnostics through Deep Learning.

About Athelas Stock

Athelas utilizes deep learning and computer vision to rapidly analyze tissue samples for diagnostics. The product is used for immune monitoring, blood counts, and parasite diagnostics.

Funding History

February 2016	$0
August 2016	$120K
January 2017	$3.5M

Management

Founder

Tanay Tandon

Product Manager

Steve Moffatt

Press

New At-Home CBC Device Enables Complete Blood Testing for Cancer Treatments and Biological/Viral Monitoring - DARKDaily.com

Laboratory News - May, 11 2018

Athelas Device Provides Accurate CBC Testing – From Home

Medgadget (blog) - Sep, 6 2017

Test your blood from the comfort of your home with Athelas

Digital Trends - Aug, 29 2017

Athelas launches a new type of blood testing device for the home

TechCrunch - Aug, 28 2017

EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 300K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Request Access

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2023 EquityZen Inc. All rights reserved.